⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARWR News
Arrowhead Research Corporation
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
businesswire.com
ARWR
Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight
globenewswire.com
AZN
IONS
ARWR
REGN
SNY
OMER
IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight
globenewswire.com
NVS
VRTX
BIIB
VTRS
AZN
IONS
TAK
ARWR
WLDN
RNA Therapies Market Research and Competitive Landscape Report 2026
globenewswire.com
NVS
ARWR
ALNY
Next Generation Drug Conjugates (NDCs) Market worth $42.55 billion by 2035 | MarketsandMarkets™
prnewswire.com
ALNY
GILD
IONQ
ABBV
ARWR
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
BIIB
NVS
VTRS
UCB
BMY
ABBV
AZN
CABA
AUR
GSK
VERA
KYMR
NKTR
VRTX
ARWR
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo
businesswire.com
ARWR
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
prnewswire.com
VRTX
CRSP
ARWR
ALT
Form 8-K
sec.gov
ARWR
National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day
prnewswire.com
IONS
ARWR
AMRN